Literature DB >> 10268539

Experiences with home hospice care: determinants of place of death.

D M Bass, E P Pestello, T N Garland.   

Abstract

During the past few years the United States has witnessed the growth of hospice care as an alternative approach for the care of the terminally ill. This paper examines a sample of patients who elected to enroll in a home hospice program. Approximately 57 percent of these patients remained at home until death. The other 43 percent chose to return to a facility where they eventually died. Evidence indicates that patients and caregivers who have more difficulty with terminal care at home are more likely to return to a facility. The analysis explores factors that explain why some patients and caregivers have a more troublesome experience with terminal care at home. Four of the factors tested are found to be related to place of death: (1) the number of visits from hospice nurses, (2) the intensity of contact with the hospice nurses, (3) length of time patients are enrolled in the hospice program, and (4) race of the patient. The implications of these findings are discussed and recommendations for delivery of hospice services are suggested.

Entities:  

Mesh:

Year:  1984        PMID: 10268539     DOI: 10.1080/07481188408252460

Source DB:  PubMed          Journal:  Death Educ        ISSN: 0145-7624


  3 in total

Review 1.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

2.  Patterns of care at end of life for people with primary intracranial tumors: lessons learned.

Authors:  Abdulrahman Alturki; Bruno Gagnon; Kevin Petrecca; Susan C Scott; Lyne Nadeau; Nancy Mayo
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

3.  Factors associated with location of death (home or hospital) of patients referred to a palliative care team.

Authors:  I R McWhinney; M J Bass; V Orr
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.